2nd Quarter - Report

THE DUBERSTEIN GROUP INC. for PFIZER INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug pricing MADE Act (H.R.3927/S.2082) Vaccine Access Improvement Act (H.R.3656) TRIPS waiver Cancer Moonshot initiative

LobbyistCovered position, as disclosed
BRIAN GRIFFIN —
BENJAMIN R HOWARD —
KATHERINE WINKLER KEATING —
ELIZABETH KELLEY —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 3656 (117th), H.R. 3927 (117th), S. 2082 (117th)

Budget/Appropriations BUD

Biosimilar utilization

LobbyistCovered position, as disclosed
DAVID J SCHIAPPA —

Contacted: SENATE

Taxation/Internal Revenue Code TAX

Excise Tax / CICP / VICP

LobbyistCovered position, as disclosed
KATHERINE WINKLER KEATING —

Contacted: HOUSE OF REPRESENTATIVES

Environment/Superfund ENV

Issues related to climate

LobbyistCovered position, as disclosed
ELIZABETH KELLEY —

Contacted: Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.